Do equity financing cycles matter? Evidence from biotechnology alliances

Journal of Financial Economics

Volumn 67, Issue 3, 2003, Pages 411-446

  Lerner, Josh ^a,b   Shane, Hilary ^c   Tsai, Alexander ^d  

^a HARVARD UNIVERSITY   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c FNY Millenium Global Offshore Ltd   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Initial public offerings; Product market financial interactions; Strategic alliances; Venture capital

Indexed keywords

EID: 0037319366     PISSN: 0304405X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-405X(02)00256-8     Document Type: Article

References (42)

1. Aghion, P., Bolton, P., 1992. An incomplete contract approach to financial contracting. Review of Economic Studies 59, 473-494.
2. Aghion, P., Tirole, J., 1994. On the management of innovation. Quarterly Journal of Economics 109, 1185-1207.
3. Aghion, P., Tirole, J., 1997. Formal and real authority in organizations. Journal of Political Economy 105, 1-29.
4. Asquith, P., Mullins Jr., D.W., 1986. Equity issues and offering dilution. Journal of Financial Economics 15, 61-89.
5. Baker, M., Wurgler, J., 2000. The equity share in new issues and aggregate stock returns. Journal of Finance 55, 2219-2257.
6. Banerjee, A.V., Duflo, E., 2000. Reputation effects and the limits of contracting: a study of the Indian software industry. Quarterly Journal of Economics 115, 989-1017.
7. Bayless, M., Chaplinsky, S., 1996. Is there a window of opportunity for seasoned equity issuance? Journal of Finance 51, 253-278.
8. Bolton, P., Scharfstein, D.S., 1990. A theory of predation based on agency problems in financial contracting. American Economic Review 80, 93-106.
9. Chan, Y.-S., 1983. On the positive role of financial intermediation in allocation of venture capital in a market with imperfect information. Journal of Finance 38, 1548-1568.
10. Choe, H., Masulis, R.W., Nanda, V., 1993. Common stock offerings across the business cycle: theory and evidence. Journal of Empirical Finance 1, 3-32.
11. Diamond, D.W., 1991. Monitoring and reputation: the choice between bank loans and directly placed debt. Journal of Political Economy 99, 688-721.
12. Dibner, M.D., editor, 1999. Biotechnology Guide USA: Companies, Data and Analysis. Macmillan, New York (and earlier years).
13. Ernst & Young, 1996. Biotech '96. Ernst & Young, San Francisco (and earlier years).
14. Grossman, S.J., Hart, O.D., 1986. The costs and benefits of ownership: a theory of lateral and vertical integration. Journal of Political Economy 94, 691-719.
15. Hart, O.D., Moore, J., 1988. Incomplete contracts and renegotiation. Econometrica 56, 755-785.
16. Henderson, R., Cockburn, I., 1996. Scale, scope, and spillovers: the determinants of research productivity in drug discovery. Rand Journal of Economics 27, 32-59.
17. Hertzel, M., Smith, R.L., 1993. Market discounts and shareholder gains for placing equity privately. Journal of Finance 48, 459-485.
18. Hickman, W.B., 1953. The Volume of Corporate Bond Financing Since 1900. National Bureau of Economic Research, Financial Research Group, Studies in Corporate Bond Financing, No. 1. Princeton University Press for the National Bureau of Economic Research, Princeton.
19. Holmstrom, B., Tirole, J., 1997. Financial intermediation, loanable funds, and the real sector. Quarterly Journal of Economics 112, 663-691.
20. Hubbard, R.G., 1998. Capital market imperfections and investment. Journal of Economic Literature 36, 1193-1225.
21. Kaplan, S.N., Zingales, L., 1997. Do investment-cash flow sensitivities provide useful measures of financing constraints? Quarterly Journal of Economics 112, 169-215.
22. Korajczyk, R.A., Lucas, D.J., McDonald, R.L., 1991. The effect of information releases on the pricing and timing of equity issues. Review of Financial Studies 4, 685-708.
23. Lee, C.M.C., Shleifer, A., Thaler, R.H., 1991. Investor sentiment and the closed-end fund puzzle. Journal of Finance 46, 75-109.
24. Leland, H., Pyle, D., 1977. Information asymmetries, financial structure, and financial intermediation. Journal of Finance 32, 371-387.
25. Lerner, J., 1994. Venture capitalists and the decision to go public. Journal of Financial Economics 35, 293-316.
26. Lerner, J., Merges, R.P., 1998. The control of technology alliances: an empirical analysis of the biotechnology industry. Journal of Industrial Economics 46, 125-156.
27. Levine, R., 1997. Financial development and economic growth: an agenda. Journal of Economic Literature 35, 688-726.
28. Lowry, M., 2001. Why does IPO volume fluctuate so much?, Unpublished working paper, Pennsylvania State University.
29. Lucas, D.J., McDonald, R.L., 1990. Equity issues and stock price dynamics. Journal of Finance 45, 1019-1043.
30. Mackie-Mason, J.K., 1990. Do firms care who provides their financing? In: Hubbard, R.G. (Ed.), Asymmetric Information, Corporate Finance, and Investment. University of Chicago Press for National Bureau of Economic Research, Chicago, pp. 63-104.
31. Masulis, R.W., Korwar, A.N., 1986. Seasoned equity offerings: an empirical investigation. Journal of Financial Economics 15, 91-118.
32. Merges, R.P., 1995. Intellectual property and the costs of commercial exchange: a review essay. Michigan Law Review 93, 1570-1615.
33. Mikkelson, W.H., Partch, M.M., 1986. Valuation effects of security offerings and the issuance process. Journal of Financial Economics 15, 31-60.
34. Milgrom, P., Roberts, J., 1992. Economics, Organization, and Management. Prentice-Hall, Englewood Cliffs, NJ.
35. Myers, S.C., Majluf, N.S., 1984. Corporate financing and investment decisions when firms have information investors do not have. Journal of Financial Economics 13, 187-221.
36. National Academy of Sciences, Board on Science, Technology, and Economic Policy, 1999. Securing America's Industrial Strength. National Academy Press, Washington.
37. Oryx Press, 1996. Bioscan. Oryx Press, Phoenix, Arizona (and earlier years).
38. Pagano, M., Panetta, F., Zingales, L., 1998. Why do companies go public? an empirical analysis. Journal of Finance 53, 27-64.
39. Petersen, M.A., Rajan, R.G., 1994. The benefits of lending relationships: evidence from small business data. Journal of Finance 49, 3-37.
40. Pharmaceutical Research and Manufacturers of America, 1998. Industry Profile 1998, http://www.pharma.org/industry/profile98.
41. Pisano, G.P., 1997. R&D performance, collaborative arrangements and the market-for-know-how: A test of the 'lemons' hypothesis in biotechnology, Harvard Business School, Working Paper No. 97-105.
42. Zucker, L.G., Darby, M.R., Brewer, M.B., 1998. Intellectual human capital and the birth of US biotechnology enterprises. American Economic Review 88, 290-306.